Severe neurological complications of hereditary erythermalgia [27]

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 10, 2007, Pages 1446-1447

  Misery, Laurent ^a   Greco M ^a   Fleuret, C ^a   Firmin, D ^a   Mocquard, Y ^a   Renault, A ^a   Roguedas, A M ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CHLORIDE; CISATRACURIUM; CLONAZEPAM; GABAPENTIN; KETAMINE; MIDAZOLAM; MORPHINE; SUFENTANIL; VENLAFAXINE;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; CONVULSION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSAUTONOMIA; ERYTHROMELALGIA; GENETIC DISORDER; HUMAN; HYDROTHERAPY; HYPOGLYCEMIA; HYPOTENSION; HYPOTHERMIA; LETTER; MALE; NEUROLOGICAL COMPLICATION; PAIN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; VISUAL HALLUCINATION;

ADULT; ERYTHROMELALGIA; HUMANS; MALE; MUTATION; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 35649007863     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02265.x     Document Type: Letter

References (10)

1. Waxman SG, Dib-Hajj D. Erythromelalgia: A hereditary pain syndrome enters the molecular era. Ann Neurol 2005; 57: 785-788.
2. Drenth JPH, te Morsche RHM, Guillet G, Taieb A, Kirby RL, Jansen JB. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005; 124: 1333-1338.
3. Freeman R. Autonomic peripheral neuropathy. Lancet 2005; 365: 1259-1270.
4. Rush AM, Dib-Hajj D, Liu S, Cummins TR, Black JA, Waxman SG. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A 2006; 103: 8245-8250.
5. Kazemi R, Shooshtari SM, Nasab MR, Roghani RS, Haghighi FM. Sympathetic skin response (SSR) in erythromelalgia. Electromyogr Clin Neurophysiol 2003; 43: 165-168.
6. Yang Y, Wang Y, Li S et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2003; 41: 171-174.
7. Davis MDP, Sandroni P, Rooke TW, Low PA. Erythromelalgia: Vasculopathy, neuropathy or both? A prospective study of vascualr and neurophysiologic studies in erythromelalgia Arch Dermatol 2003; 139: 1337-1343.
8. Orstavik K, Weidner C, Schmidt R et al. Pathological C-fibres in patients with a chronic painful condition. Brain 2003; 126: 1-12.
9. Davis MDP, Genebriera J, Sandroni P, Fealey RD. Thermoregulatory sweat testing in patients with erythromelalgia. Arch Dermatol 2006; 142: 1583-1588.
10. Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 2004; 24: 8232-8236.